Rydex Biotechnology C (RYCFX)
Nasdaq - Nasdaq Delayed price. Currency in USD
Add to watchlist
At close: 08:00PM EDT
Overall portfolio composition (%)
Cash0.86%
Stocks99.68%
Bonds0.00%
Others-0.54%
Preferred0.00%
Convertible0.00%
Sector weightings (%)
Sector(s)RYCFX
Basic materials3.37%
Consumer cyclical0.00%
Financial services0.00%
Property0.00%
Consumer defensive0.00%
Healthcare96.63%
Utilities0.00%
Communication services0.00%
Energy0.00%
Industrials0.00%
Technology0.00%
Equity holdings
AverageRYCFXCategory average
Price/Earnings0.0424.55
Price/book0.275.28
Price/sales0.192.06
Price/Cash flow0.0717.54
Median market cap22,220.1934,862.81
3-year earnings growth9.5932.48
Bond holdings
AverageRYCFXCategory average
MaturityN/AN/A
DurationN/AN/A
Credit qualityN/AN/A
Bond ratings
Sector(s)RYCFX
US government0.00%
AAAN/A
AAN/A
AN/A
BBBN/A
BBN/A
BN/A
Below BN/A
OthersN/A
Top 10 holdings (42.79% of total assets)
Get quotes for top holdings| Name | Symbol | % assets |
|---|---|---|
| AbbVie Inc | ABBV | 8.08% |
| Amgen Inc | AMGN | 6.15% |
| Regeneron Pharmaceuticals Inc | REGN | 4.96% |
| Vertex Pharmaceuticals Inc | VRTX | 4.21% |
| Moderna Inc | MRNA | 3.69% |
| Gilead Sciences Inc | GILD | 3.59% |
| Corteva Inc | CTVA | 3.36% |
| AstraZeneca PLC ADR | AZN | 3.33% |
| Biogen Inc | BIIB | 3.11% |
| Alnylam Pharmaceuticals Inc | ALNY | 2.31% |
© 2024 Yahoo. All rights reserved.